跳至主要内容
临床试验/CTRI/2022/02/040088
CTRI/2022/02/040088已完成3 期

Impact of Ayuraksha Kit in Covid-19- Community Based Prophylactic Study

Ministry of Tribal Affairs0 个研究点目标入组 30,800 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
30,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Participants not having COVID-19 like symptoms, of age between 18 – 70 years, of any sex from the identified scheduled Tribe predominant areas/villages across India
  • b)Participants who are ready to provide informed consent.

排除标准

  • i.Participants presenting with COVID-19 like symptoms
  • ii.Participants diagnosed as case of COVID-19 by positive RT-PCR test within one month prior to inclusion
  • iii.History of uncontrolled Diabetes mellitus or uncontrolled Hypertension
  • iv.Participants having any disease condition that would require immediate medical or surgical intervention
  • v.Known case of immune compromised state like HIV
  • vi.Known cases of COPD, Tuberculosis, Cancer, Hepatitis
  • vii.Participants on steroids or any immunosuppressive therapy
  • viii.Those who have participated in any other clinical trial within one month prior to screening
  • ix.Participants having a history of allergy to any medicine that is part of Ayuraksha Kit
  • x.Women who are Pregnant or are planning for pregnancy during the study period or those who are lactating mothers

研究者

相似试验